Osteoporosis Prevention in Preadolescent Girls
This study will test an osteoporosis prevention program aimed at preadolescent girls between the ages of 10 and 12 who have not yet started their menstrual periods. Girls in this age group are adding large amounts of new bone to their skeletons. Adding more bone at this time of life can reduce a person’s chances of developing osteoporosis (thinning bones) in later years.
We will look at how this osteoporosis prevention program affects the amount of calcium in the girls’ diets, the amount of weight-bearing exercise they do, and their bone mass measured using ultrasound testing of the heel.
Description
The study’s objective is to demonstrate the efficacy of a behavioral/educational intervention in increasing levels of dietary calcium intake and weight-bearing exercise within an at-risk population in a stage of rapid accrual of bone mass-specifically, premenarchal girls between the ages of 10 and 12. We will use cluster randomization to randomize girls to either the intervention or a program of education only. We will randomize eighteen groups of girls into each arm of the study.
The intervention consists of six interactive sessions using various media (i.e., overhead transparencies, graphics, and three-dimensional demonstrations) to present instructional material. Topics include an explanation of osteoporosis and its modifiable and nonmodifiable risk factors, prevention of osteoporosis via healthy food choices (i.e., high calcium, low fat foods), and prevention of osteoporosis via weight-bearing exercise. Each girl monitors her own progress toward the goal of 1350 to 1500 milligrams of calcium per day. A similar method allows simple self-monitoring of weight-bearing activity. The intervention program is reinforced via monthly self-monitoring for 18 months. The education-only program consists of six generic sessions on healthy eating, physical fitness, and healthy lifestyle choices.
The primary outcomes of interest are higher calcium intake and higher levels of weight-bearing exercise. A secondary outcome of interest is increased broadband ultrasound attenuation of the os calcis, assessed using quantitative ultrasound. In summary, the group of girls targeted is ideal for this intervention because they are at a stage of rapid accrual of bone mass.
Status: Completed (Phase 2). Started on July 1st, 1998. Ended on June 1st, 2002.
Enrollment: 340 subjects
Study Type: Interventional
Study Design:
- Prevention
- Randomized
- Single Blind
- Active Control
- Parallel Assignment
- Efficacy Study
Conditions:
Interventions:
- Behavioral: Psychoeducational program
Eligibility
Inclusion Criteria:
- 9- and 10-year-old premenarchal girls (girls who have not started their periods).
Exclusion Criteria:
- Comorbid conditions or medications that are associated with decreased bone density such as the following: corticosteroids; anticonvulsants; thiazide diuretics; history of cancer; Type I diabetes; thyrotoxicosis; hyperparathyroidism; Cushing’s syndrome; juvenile rheumatoid arthritis; connective tissue disease or hemolytic anemia; asthma which may limit ability to participate in the exercise intervention; known history of dietary disorder, including anorexia, bulimia or lactose intolerance; postmenarchal.
- Gender
Female
- Mininum Age
9 Years
- Maximum Age
13 Years
- Healthy Volunteers
Accepts Healthy Volunteers
Resources
Source: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Authority: United States: Federal Government
Locations
-
University Hospitals of Cleveland
Cleveland
Ohio
44106
United States
Officials
C. Kent Kwoh, MD (Principal Investigator, Case Western Reserve Univ. and Univ. Pittsburgh)
Sponsors
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (Lead Sponsor)
References
Ievers-Landis CE, Burant C, Drotar D, Morgan L, Trapl ES, Kwoh CK. Social support, knowledge, and self-efficacy as correlates of osteoporosis preventive behaviors among preadolescent females. J Pediatr Psychol. 2003 Jul-Aug;28(5):335-45.
PMID: 12808010.
Check for Full Text
Links
None.
- Date Verified
- February 1st, 2003
- First Received
- December 28th, 2006
- Last Changed
- December 28th, 2006
Information obtained from ClinicalTrials.gov on July 15, 2008. Link to the current ClinicalTrials.gov record.
All data in the Healia Clinical Trials Information Database and content displayed by the Healia Clinical Trials Search Engine are licensed from the National Institutes of Health (National Library of Medicine), which collects and maintains the data.
The Healia Clinical Trials Search Engine searches the data set at clinicaltrials.gov, providing up-to-date information about current clinical trials. In the Healia Clinical Trials Database you can find information on new experimental drugs, medical devices, and other types of treatments for all types of diseases. Each clinical trial description includes information about the phase of the trial (phase I, phase II, or phase III), the trial’s methods, such as whether it is a randomized, placebo controlled, double blind study, and the status of the trial including whether or not the trial is currently enrolling new participants.